ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Mrs. Ingrid has cancer.

Patient basic information Patient: Ms. Ingrid Harris) Nationality: Tanzania Diagnosis: Pancreatic Cancer Diagnostic Hospital: H0ZN Treatment: Insulin-based treatment + medication Holidays: 113 days Treatment cost: approximately 1456888 yuan Treatment effect: Complete relief The patient is from Tanzania and was diagnosed with pancreatic cancer locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process.

After 113 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and various test indicators returned to normal areas, successfully reaching the hospital standard. The treatment effect was finally completely relaxed. When the patient left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track the recovery through a remote follow-up system.

The patients commented: 'The level of expertise of Chinese doctors and the condition of equipment in Chinese hospitals impressed us, and every link from the ground to the hospital was arranged with a well. 'Mrs. Ingrid, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases.

The multi-disciplinary collaborative mechanism for the development of intracellular therapy + drug regimens for pancreatic cancer reflects the comprehensive strength of Chinese hospitals in the field of suspected disease clinics and a summary of how international medical services are regulated.

坦桑尼亚,胰腺癌,北京大学第三医院,国际医疗,来华就医,中国医疗